Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease

2.

Alsaied

T

,

Niss

O

,

Tretter

JT

, et al.

Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacity

.

Sci Rep

.

2020

;

10

(

1

):

1767

.

3.

Bakeer

N

,

James

J

,

Roy

S

, et al.

Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology

.

Proc Natl Acad Sci U S A

.

2016

;

113

(

35

):

E5182

-

E5191

.

4.

Morin

CE

,

Sharma

A

,

Selukar

S

, et al.

Diffuse myocardial fibrosis occurs in young patients with sickle cell anemia despite early disease-modifying therapy

.

Blood

.

2023

;

141

(

11

):

1358

-

1362

.

5.

Niss

O

,

Detterich

J

,

Wood

JC

, et al.

Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia

.

Blood

.

2022

;

140

(

11

):

1322

-

1324

.

6.

Sibley

CT

,

Noureldin

RA

,

Gai

N

, et al.

T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy

.

Radiology

.

2012

;

265

(

3

):

724

-

732

.

7.

Diao

KY

,

Yang

ZG

,

Xu

HY

, et al.

Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis

.

J Cardiovasc Magn Reson

.

2016

;

18

(

1

):

92

.

8.

Kellman

P

,

Wilson

JR

,

Xue

H

,

Ugander

M

,

Arai

AE

.

Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method

.

J Cardiovasc Magn Reson

.

2012

;

14

(

1

):

63

.

9.

Melendez

GC

,

Jordan

JH

,

D'Agostino

RB

,

Vasu

S

,

Hamilton

CA

,

Hundley

WG

.

Progressive 3-month increase in LV myocardial ECV after anthracycline-based chemotherapy

.

JACC Cardiovasc Imaging

.

2017

;

10

(

6

):

708

-

709

.

10.

Morita

N

,

Mandel

WJ

,

Kobayashi

Y

,

Karagueuzian

HS

.

Cardiac fibrosis as a determinant of ventricular tachyarrhythmias

.

J Arrhythm

.

2014

;

30

(

6

):

389

-

394

.

11.

d'Humieres

T

,

Saba

J

,

Savale

L

, et al.

Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death

.

Blood

.

2023

;

142

(

5

):

409

-

420

.

12.

Nagueh

SF

,

Smiseth

OA

,

Appleton

CP

, et al.

Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

.

Eur Heart J Cardiovasc Imaging

.

2016

;

17

(

12

):

1321

-

1360

.

13.

Haaf

P

,

Garg

P

,

Messroghli

DR

,

Broadbent

DA

,

Greenwood

JP

,

Plein

S

.

Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review

.

J Cardiovasc Magn Reson

.

2016

;

18

(

1

):

89

.

14.

Stenger

E

,

Abraham

A

,

Travers

CD

, et al.

Development of a multi-center cohort to evaluate long-term outcomes and late effects following hematopoietic cell transplantation for sickle cell disease: a STAR initiative

.

Blood

.

2017

;

130

(

Supplement 1

):

3271

.

15.

Dallas

MH

,

Triplett

B

,

Shook

DR

, et al.

Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease

.

Biol Blood Marrow Transplant

.

2013

;

19

(

5

):

820

-

830

.

16.

Covi

S

,

Ravindranath

Y

,

Farooqi

A

,

Savasan

S

,

Chu

R

,

Aggarwal

S

.

Changes in bi-ventricular function after hematopoietic stem cell transplant as assessed by speckle tracking echocardiography

.

Pediatr Cardiol

.

2018

;

39

(

2

):

365

-

374

.

17.

Karamitsos

TD

,

Arvanitaki

A

,

Karvounis

H

,

Neubauer

S

,

Ferreira

VM

.

Myocardial tissue characterization and fibrosis by imaging

.

JACC Cardiovasc Imaging

.

2020

;

13

(

5

):

1221

-

1234

.

18.

Thein

SL

,

Sachdev

V

.

Diffuse myocardial fibrosis as an SCD biomarker

.

Blood

.

2022

;

140

(

11

):

1191

-

1192

.

19.

Paszty

C

,

Brion

CM

,

Manci

E

, et al.

Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease

.

Science

.

1997

;

278

(

5339

):

876

-

878

.

20.

Galan-Arriola

C

,

Lobo

M

,

Vilchez-Tschischke

JP

, et al.

Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity

.

J Am Coll Cardiol

.

2019

;

73

(

7

):

779

-

791

.

21.

Kwiecinski

J

,

Lennen

RJ

,

Gray

GA

, et al.

Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy

.

J Cardiovasc Magn Reson

.

2020

;

22

(

1

):

57

.

22.

Melendez

GC

,

Kavanagh

K

,

Gharraee

N

, et al.

Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes

.

Biomed Pharmacother

.

2023

;

160

:

114365

.

23.

Lopez

B

,

Ravassa

S

,

Moreno

MU

, et al.

Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

.

Nat Rev Cardiol

.

2021

;

18

(

7

):

479

-

498

.

24.

Meloni

A

,

Pistoia

L

,

Quota

A

, et al.

Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients

.

Ann Hematol

.

2023

;

102

(

2

):

261

-

270

.